There is growing interest in increasing the use and relevance of patient preferences studies among decision makers in health. The task force focused on developing a new framework that would: 1) be applicable to the wide variety of preference methods; 2) identify key domains that would guide researchers and other stakeholders in making patient preference studies more useful to decision makers; and 3) detail important questions that would guide researchers conducting preference studies and those critically appraising them.

The framework spans 5 domains for conducting patient preference studies to increase the use and relevance of these studies to decision makers:

1. The context – A complete understanding of how decision makers function, how decisions are made, and how studies on patient preferences may be received and used.
2. The purpose – A clear articulation of how the study on patient preferences responds to decision makers’ needs and how the findings are expected to inform decision making.

• The population – A thorough consideration of who the findings of the study will be applied to (directly or indirectly) and the intended and unintended consequences for those people.

1. The method – A selection of method/s to study patient preferences that reflects the needs, wants, and capabilities of decision makers, patients, and other stakeholders.
2. The impact – A proactive effort both to ensure that the study findings can inform decision making and to measure if and how they influenced decision makers and decision-making.

Dr. Heidenreich will introduce the session and moderate the Q & A session. Dr. Debekker-Grob will present the ISPOR Patient Preference Roadmap. Mr Low will present the patient perspective and Dr. Bouvy present the HTA perspective.